diabetes

By Mel J. Yeates

Encouraging results for tirzepatide in diabetes

Topline data from a recent Eli Lilly clinical trial indicate that tirzepatide led to superior A1C and body weight reductions from baseline compared to injectable semaglutide in adults with type 2 diabetes.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

September 2022

Latest Issue  

• Volume 18 • Issue 9 • September 2022

September 2022

September 2022